Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bt-11
2. 1912399-75-7
3. A4y49h6yy8
4. Chembl4788758
5. Piperazine-1,4-diylbis((6-(1h-benzo[d]imidazol-2-yl)pyridin-2-yl)methanone)
6. [4-[6-(1h-benzimidazol-2-yl)pyridine-2-carbonyl]piperazin-1-yl]-[6-(1h-benzimidazol-2-yl)pyridin-2-yl]methanone
7. Omilancor
8. Omilancor [inn]
9. Unii-a4y49h6yy8
10. Bt11
11. Schembl17706588
12. Gtpl10363
13. Bcp32788
14. Bt 11; Bt11
15. Example 1 [us9556146b2]
16. Bdbm50558735
17. S6419
18. Akos037515592
19. Cs-7521
20. Sb18706
21. Hy-102013
22. J3.612.231e
Molecular Weight | 528.6 g/mol |
---|---|
Molecular Formula | C30H24N8O2 |
XLogP3 | 3.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 124 |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 840 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Omilancor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Omilancor, including repackagers and relabelers. The FDA regulates Omilancor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Omilancor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Omilancor supplier is an individual or a company that provides Omilancor active pharmaceutical ingredient (API) or Omilancor finished formulations upon request. The Omilancor suppliers may include Omilancor API manufacturers, exporters, distributors and traders.
Omilancor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Omilancor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Omilancor GMP manufacturer or Omilancor GMP API supplier for your needs.
A Omilancor CoA (Certificate of Analysis) is a formal document that attests to Omilancor's compliance with Omilancor specifications and serves as a tool for batch-level quality control.
Omilancor CoA mostly includes findings from lab analyses of a specific batch. For each Omilancor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Omilancor may be tested according to a variety of international standards, such as European Pharmacopoeia (Omilancor EP), Omilancor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Omilancor USP).
LOOKING FOR A SUPPLIER?